Takeda To Create Database Of Genes, Diseases To Speed Drug Discovery
This article was originally published in PharmAsia News
Takeda Pharmaceuticals is creating a database it expects to use to explore ties genes have to diseases, enabling it to discover possible links to new treatments more quickly.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.